TEM (Tempus AI, Inc.) Bozor qiymatining balans qiymatiga nisbati
Tempus AI, Inc (TEM) tibbiyotni shaxsiylashtirish uchun onkologiya ekspertlari va AI texnologiyalarini birlashtirib, turli imkoniyatlar orqali o'sishni ta'minlamoqda. Kompaniya hisoblash jarayonlarini yashil energiyaga o'tkazish orqali ekologik izini minimallashtirmoqda, shu bilan birga klinika va sog'liqni saqlash gigantlari o'rtasidagi ma'lumotlar almashinuvi orqali tarmoq effekti yaratilmoqda. Ushbu P/B koeffitsiyenti grafigi korporativ yangiliklarga bozorning reaksiyasini namoyish etadi, bunda ko'rsatkich hozirda 27.38 darajasida turibdi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_TEM_-_Tempus-AI-Inc_-_Capitalization-to-Book-Value-Ratio "TEM Tempus AI Bozor kapitallashuvining balans qiymatiga nisbati (15.06.2024 - 27.10.2026) | 👁️GURU.Markets👁️")
tempus.com (TEM) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Fundamental baholash:TEM Tempus AI, Inc.
Tempus AI, Inc (TEM) kompaniyasidagi biomateriallar uchun murakkab sovuq zanjir logistikasi kapital xarajatlarini sezilarli darajada oshirib, sekvenslash uchun real aktivlar bazasini shakllantiradi. Buxgalteriya qiymatiga nisbatan narx koeffitsiyentini tahlil qilish orqali investor sof aktivlarga nisbatan bozor narxining koeffitsiyentini aniqlaydi, bu esa biznes premiumini baholash yoki kapitalning qadrsizlanish xatarlarini aniqlash imkonini beradi.
Asosiy raqobatchilar
Bozor kapitallashuvining balans qiymatiga nisbati Qiagen N.V.|IONS (ionispharma.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Repligen (RGEN)|Kapitallashuvning balans qiymatiga nisbati Avidity Biosciences Inc|Bozor kapitallashuvining balans qiymatiga nisbati CRSP|Bozor kapitallashuvining balans qiymatiga nisbati GeneDx Corp WGS|Kapitallashuvning sof aktivlarga nisbati Ultragenyx Pharmaceutical (RARE)|Bozor kapitallashuvining balans qiymatiga multiplikatori beamtx.com BEAM|SRPT (Sarepta) - Bozor kapitallashuvining balans qiymatiga nisbati|TWST: Bozor qiymatining balans qiymatiga koeffitsiyenti|TXG (10x Genomics Corp) - Bozor qiymatining balans qiymatiga nisbati|NTLA (Intellia Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Stoke Therapeutics STOK|Sof aktivlarga nisbatan bozor kapitallashuvi biolifesolutions.com (BLFS)|Kapitallashuvning sof aktivlarga nisbati WVE|Bozor kapitallashuvining balans qiymatiga nisbati MAZE (Maze Therapeutics, Inc.)|Bozor qiymatining balans qiymatiga nisbati SION|PRME - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Taysha Gene Therapies (TSHA)|QURE - Balans qiymatiga nisbatan bozor qiymati|MGTX: Bozor kapitallashuvining balans qiymatiga nisbati|REGENXBIO Inc (RGNX) - Bozor kapitallashuvining balans qiymatiga nisbati|SLDB: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Ocugen Pharma (OCGN)|Pacific Biosciences (PACB) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati benitec.com (BNTC)|Bozor kapitallashuvining balans qiymatiga nisbati DSGN|Rocket Pharma - Balans qiymatiga nisbatan bozor kapitallashuvi|4D Molecular Therapeutics Inc (FDMT) - Bozor qiymatining balans qiymatiga nisbati|LXEO - Kapitallashuvning balans qiymatiga nisbati|KRRO (korrobio.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati editasmedicine.com|Silence Therapeutics plc (SLN) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori ProQR Therapeutics NV|Codexis, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti SGMO (Sangamo BioSciences)|Nautilus Bio - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati metagenomi.co MGX|Precision BioSciences (DTIL) - Bozor kapitallashuvining balans qiymatiga nisbati|GBIO: Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Boundless Bio, Inc|Exicure (XCUR) - Kapitallashuvning balans qiymatiga nisbati|IMNN (Imunon Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RXi Pharmaceuticals (PHIO)|Kapitallashuvning sof aktivlarga nisbati Mustang Bio, Inc.|Bozor kapitallashuvining balans qiymatiga multiplikatori transcodetherapeutics.com (RNAZ)|BNGO: Bozor kapitallashuvining balans qiymatiga nisbati|Applied DNA Corp - Bozor qiymatining balans qiymatiga koeffitsiyenti|BLUE: Bozor qiymatining balans qiymatiga nisbati|IPA: Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Omega Therapeutics, Inc. (OMGA)|Sof aktivlarga nisbatan bozor kapitallashuvi Singular Genomics Systems, Inc.|RGLS (Regulus Therapeutics Inc) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SYRS|TBIO (Telesis Bio, Inc.) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi traconpharma.com TCON|Kapitallashuvning sof aktivlarga nisbati Unity Biotechnology, Inc.